17.01.2013 13:35 Uhr, Quelle: Wallstreet online
Alimera Sciences´ ILUVIEN® Receives Marketing Authorization In Spain For The Treatment Of Chronic Diabetic Macular Edema
ATLANTA, Jan. 17, 2013 /PRNewswire/ Alimera Sciences, Inc., (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced the Spanish …
Weiterlesen bei Wallstreet online
JustMac.info